3289 related articles for article (PubMed ID: 12640322)
1. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
4. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
Bralet MC; Yon V; Loas G; Noisette C
Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
[TBL] [Abstract][Full Text] [Related]
5. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
[TBL] [Abstract][Full Text] [Related]
6. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
7. [Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].
Bouhlel S; M'solly M; Benhawala S; Jones Y; El-Hechmi Z
Encephale; 2013 Feb; 39(1):6-12. PubMed ID: 23095582
[TBL] [Abstract][Full Text] [Related]
8. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
9. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
10. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
[TBL] [Abstract][Full Text] [Related]
11. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.
Coulston CM; Perdices M; Tennant CC
Schizophr Res; 2007 Nov; 96(1-3):169-84. PubMed ID: 17826035
[TBL] [Abstract][Full Text] [Related]
12. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
[TBL] [Abstract][Full Text] [Related]
13. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
[TBL] [Abstract][Full Text] [Related]
14. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
Dubertret C; Bidard I; Adès J; Gorwood P
Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
[TBL] [Abstract][Full Text] [Related]
15. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
Kazour F; Awaida C; Souaiby L; Richa S
Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
[TBL] [Abstract][Full Text] [Related]
16. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
Batki SL; Leontieva L; Dimmock JA; Ploutz-Snyder R
Schizophr Res; 2008 Oct; 105(1-3):201-7. PubMed ID: 18701256
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
Mueser KT; Yarnold PR; Levinson DF; Singh H; Bellack AS; Kee K; Morrison RL; Yadalam KG
Schizophr Bull; 1990; 16(1):31-56. PubMed ID: 2333480
[TBL] [Abstract][Full Text] [Related]
18. Suicide attempts in schizophrenic patients: clinical variables.
Mauri MC; Paletta S; Maffini M; Moliterno D; Altamura AC
Asian J Psychiatr; 2013 Oct; 6(5):421-7. PubMed ID: 24011691
[TBL] [Abstract][Full Text] [Related]
19. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
20. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
